High Levels of Immunoexpression of the Endothelial Cell Proliferation Marker CD105 Predict for Local Failure in Early-Stage Cervical Cancer
Publication
, Conference
Meyer, J; Rabbani, Z; Bentley, R; Havrilesky, L; Secord, A; Kirkpatrick, J; Dewhirst, M; Jones, E; Vujaskovic, Z
Published in: International Journal of Radiation Oncology*Biology*Physics
October 2005
Duke Scholars
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
October 2005
Volume
63
Start / End Page
S216 / S217
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Meyer, J., Rabbani, Z., Bentley, R., Havrilesky, L., Secord, A., Kirkpatrick, J., … Vujaskovic, Z. (2005). High Levels of Immunoexpression of the Endothelial Cell Proliferation Marker CD105 Predict for Local Failure in Early-Stage Cervical Cancer. In International Journal of Radiation Oncology*Biology*Physics (Vol. 63, pp. S216–S217). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2005.07.372
Meyer, J., Z. Rabbani, R. Bentley, L. Havrilesky, A. Secord, J. Kirkpatrick, M. Dewhirst, E. Jones, and Z. Vujaskovic. “High Levels of Immunoexpression of the Endothelial Cell Proliferation Marker CD105 Predict for Local Failure in Early-Stage Cervical Cancer.” In International Journal of Radiation Oncology*Biology*Physics, 63:S216–17. Elsevier BV, 2005. https://doi.org/10.1016/j.ijrobp.2005.07.372.
Meyer J, Rabbani Z, Bentley R, Havrilesky L, Secord A, Kirkpatrick J, et al. High Levels of Immunoexpression of the Endothelial Cell Proliferation Marker CD105 Predict for Local Failure in Early-Stage Cervical Cancer. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2005. p. S216–7.
Meyer, J., et al. “High Levels of Immunoexpression of the Endothelial Cell Proliferation Marker CD105 Predict for Local Failure in Early-Stage Cervical Cancer.” International Journal of Radiation Oncology*Biology*Physics, vol. 63, Elsevier BV, 2005, pp. S216–17. Crossref, doi:10.1016/j.ijrobp.2005.07.372.
Meyer J, Rabbani Z, Bentley R, Havrilesky L, Secord A, Kirkpatrick J, Dewhirst M, Jones E, Vujaskovic Z. High Levels of Immunoexpression of the Endothelial Cell Proliferation Marker CD105 Predict for Local Failure in Early-Stage Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2005. p. S216–S217.
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
October 2005
Volume
63
Start / End Page
S216 / S217
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences